|
(4Z,8E,10Z,13Z,16Z,19Z)-7-hydroxydocosahexaenoic acid |
|
CHEBI:72623 |
|
(4Z,8E,10Z,13Z,16Z,19Z)-7-hydroxydocosahexaenoic acid |
|
A hydroxydocosahexaenoic acid that consists of (4Z,8E,10Z,13Z,16Z,19Z)-docosahexaenoic acid bearing an additional 7-hydroxy substituent. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
Bijay
|
|
CHEBI:140249
|
|
|
|
Molfile
XML
SDF
|
|
more structures >>
|
|
|
InChI=1S/C22H32O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-21(23)19-16-14-17-20-22(24)25/h3-4,6-7,9-10,12-16,18,21,23H,2,5,8,11,17,19-20H2,1H3,(H,24,25)/b4-3-,7-6-,10-9-,13-12-,16-14-,18-15+ |
OZXAIGIRPOOJTI-XJAVJPOHSA-N |
C(C(O)=O)C/C=C\CC(/C=C/C=C\C/C=C\C/C=C\C/C=C\CC)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via hydroxydocosahexaenoic acid )
|
|
View more via ChEBI Ontology
Outgoing
|
(4Z,8E,10Z,13Z,16Z,19Z)-7-hydroxydocosahexaenoic acid
(CHEBI:72623)
has role
human xenobiotic metabolite
(CHEBI:76967)
(4Z,8E,10Z,13Z,16Z,19Z)-7-hydroxydocosahexaenoic acid
(CHEBI:72623)
is a
hydroxydocosahexaenoic acid
(CHEBI:72790)
(4Z,8E,10Z,13Z,16Z,19Z)-7-hydroxydocosahexaenoic acid
(CHEBI:72623)
is conjugate acid of
(4Z,8E,10Z,13Z,16Z,19Z)-7-hydroxydocosahexaenoate
(CHEBI:140373)
|
|
Incoming
|
(4Z,8E,10Z,13Z,16Z,19Z)-7-hydroxydocosahexaenoate
(CHEBI:140373)
is conjugate base of
(4Z,8E,10Z,13Z,16Z,19Z)-7-hydroxydocosahexaenoic acid
(CHEBI:72623)
|
(4Z,8E,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoic acid
|
(4Z,8Z,10Z,13Z,16Z,19Z)-7-Hydroxy-4,8,10,13,16,19-docosahexaenoic acid
|
HMDB
|
7-HDHA
|
SUBMITTER
|
7-HDoHE
|
LIPID MAPS
|
7-hydroxy-4Z,8E,10Z,13Z,16Z,19Z-docosahexaenoic acid
|
LIPID MAPS
|
7-hydroxydocosahexaenoic acid
|
ChEBI
|
26339618
|
PubMed citation
|
Europe PMC
|
|